Villanueva, Esmeregildo E.

HRN: 13-56-50  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/16/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
12/16/2025
12/23/2025
IV
600mg Iv
Q8h
Cellulitis
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: